These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4354410)

  • 21. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 22. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monoaminergic theories in depressive illness (author's transl)].
    Zarifian E
    Ann Biol Clin (Paris); 1979; 37(1):21-6. PubMed ID: 443609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
    Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA
    Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078
    [No Abstract]   [Full Text] [Related]  

  • 25. Deductive approaches to the catecholamine hypothesis of affective disorders.
    Wittenborn JR
    J Nerv Ment Dis; 1974 May; 158(5):320-4. PubMed ID: 4823932
    [No Abstract]   [Full Text] [Related]  

  • 26. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholamine metabolism: basic aspects and clinical significance.
    Kopin IJ
    Pharmacol Rev; 1985 Dec; 37(4):333-64. PubMed ID: 3915090
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
    Kato N; Takahashi S; Tani N; Iwase N; Odani K
    Alcohol Clin Exp Res; 1979 Jan; 3(1):24-7. PubMed ID: 371446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoamine and monoamine enzyme abnormalities in childhood autism].
    Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
    Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biogenic amines in the developing brain.
    Eiduson S
    UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy-resistant depressions: biochemical and pharmacological considerations.
    van Praag HM
    Int J Psychiatry Med; 1975; 6(1-2):99-111. PubMed ID: 773865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoamines and the regulation of wakefulness. I. Contribution and biochemical interpretation of the polygraphic data].
    Mouret JR; Renaud B; Quenin P; Michel D; Schott B
    Rev Neurol (Paris); 1972 Jul; 127(1):139-55. PubMed ID: 4358572
    [No Abstract]   [Full Text] [Related]  

  • 36. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 37. Modified amine hypothesis for the aetiology of affective illness.
    Lancet; 1972 Sep; 2(7777):573-7. PubMed ID: 4115743
    [No Abstract]   [Full Text] [Related]  

  • 38. [Critical view of biochemical factors in depressive syndromes and the prescription of antidepressants].
    Loo H; Zarifian E
    Ann Med Psychol (Paris); 1982 Feb; 140(2):240-51. PubMed ID: 6180668
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroendocrine aspects of the relief of melancholia by induced seizures (electroconvulsive treatment).
    Fink M
    Adv Biochem Psychopharmacol; 1984; 39():345-57. PubMed ID: 6205561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemical basis of endogenous depression (author's transl)].
    Beckmann H
    Nervenarzt; 1978 Oct; 49(10):557-68. PubMed ID: 214722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.